partner known as the retinoid X receptor (RXR 
Figure 1. Generation and Analysis of an FXR/BAR Null Mouse (A) Construction of FXR/BAR targeting vector. (B) Homologous recombination of the FXR/BAR targeted allele mediated by Cre recombinase. (C) PCR genotyping of wild-type (lane 1), heterozygous (lane 2), and homozygous (lane 3)
FXR/BAR null mice using the primers F1, F2, and R1. The PCR products (249 bp for wild-type, 291 bp for FXR/BAR null) were separated on a 2% agarose gel. (D) Northern blot analysis of mouse liver FXR/BAR mRNA expression. Hepatic mRNA (2 g) from wild-type (ϩ/ϩ) or FXR/BAR null mice (Ϫ/Ϫ) mice was separated on a 1.1% agarose gel, transferred to a nylon membrane, and hybridized with the indicated 32 P-labeled cDNA probes. The exon probe is homologous to the deleted exon from the FXR/BAR gene of (Ϫ/Ϫ), the cDNA probe is homologous to the full-length transcript from (ϩ/ϩ) mice, and the KO probe is homologous with the unique sequence present within the null mouse mRNA. ␤-actin was used as a loading control. (E) Western blot analysis of mouse liver FXR/BAR protein expression. Hepatic nuclear protein (80 g) was separated by SDS-PAGE (10%) and transferred to a nitrocellulose membrane. A goat polyclonal antibody raised against the C-terminal of FXR/BAR was used to assess FXR/ BAR protein expression. The blots were reprobed with an antibody to HNF-4␣ in order to verify loading and the presence of nuclear proteins in the samples. Lane 1, 1 l of sonicate prepared from E. coli expressing murine FXR/BAR; lane 2, wild-type mouse liver; lane 3, FXR/BAR null mouse liver. Note that the bacterial expressed recombinant protein is 14 amino acids longer than the native protein due to the addition of a C-terminal histidine tag and adjacent residues encoded by expression vector sequence. A, AvrII; Ap, ApaI; B, BamHI; E, EcoRV; H, HindIII; N, NcoI; X, XbaI.
homeostasis, a mouse with a targeted disruption of the Southern blot (data not shown) and PCR analysis ( Figure  1C ) of genomic DNA confirmed the predicted recombi-FXR/BAR gene was constructed. These mice lack funcnation event after crossing mice homozygous for the tional FXR/BAR and are unable to correctly control BA targeted allele with transgenic mice expressing bactebiosynthesis and excretion. The expression of a number riophage P1 Cre recombinase under the control of the of target genes relevant to these processes, including adenovirus EIIA promoter. Northern blot analysis of liver Cyp7a and I-BABP, was shown to be regulated in an mRNA from FXR/BAR null (Ϫ/Ϫ) mice using a cDNA FXR/BAR-dependent manner in vivo. These mice also probe homologous to the deleted exon indicated the exhibit a potential proatherogenic serum lipoprotein absence of a wild-type transcript encoding this portion profile characterized by markedly elevated serum and of the gene ( Figure 1D ). Western blot analysis using an liver cholesterol and triglycerides. ‫%03ف‬ of the null mice by day 7. In stark contrast, wildfollowed by 435 bp of unique sequence that exhibited type mice appeared to tolerate the CA diet well and no significant homology to any previously characterized displayed no overt signs of toxicity or mortality after day sequence. A cDNA probe consisting of this unique se-7. Based on these results, we focused the majority of quence detected the null transcript only in the FXR/BAR our studies on mice fed the CA diet for 5 days since by null mouse liver mRNA sample ( Figure 1D ). This novel this time toxicity was readily apparent but mortality was sequence is most likely derived from intron sequence minimal. Feeding of the 1% CA diet to FXR/BAR null of the FXR/BAR gene that is not removed during promice resulted in a progressive decrease in body weight cessing of the primary transcript of the null allele. The that amounted to approximately one-third of the initial null transcript possesses a poly(A) signal sequence (AAT body weight by day 5, while wild-type mice exhibited AAA) 18 bp upstream of the poly(A) tail that most likely no significant decrease of body weight (Figure 2A ). Liver arises fortuitously as a consequence of the relative to body weight ratios were similar for both genotypes abundance of these short sequences within genomic maintained on either diet, indicating an absence of hepa-DNA. Translation of the null-specific mRNA predicts a tomegaly in FXR/BAR null mice ( Figure 2B ). Total serum protein of 376 amino acids compared with the 451 amino BA concentrations were ‫-8ف‬fold greater for null mice acid product of the wild-type mice transcript. maintained on a control diet than that for wild-type mice fed the same diet ( Figure 2C hepatotoxicity were present in FXR/BAR null mice fed much higher (7-fold) excretion rates compared with wildtype mice. These data indicate that FXR/BAR null mice the CA diet, with numerous vacuolated and necrotic cells evident by day 5 ( Figure 3B ). These data indicate were deficient for hepatic BA uptake from the blood and/or hepatic canalicular BA secretion. that FXR/BAR null mice have a reduced capacity to excrete BAs.
As an indicator of the secretion of BAs from the liver, total BA pools as well as fecal and urinary BA excretion Defects of Lipid Homeostasis in FXR/BAR Null Mice were measured. As shown in Figure 2D , wild-type animals fed the control diet had a BA pool 2-fold greater CYP7A, the rate-limiting enzyme in the elimination of cholesterol via conversion to BAs, is regulated in an than FXR/BAR null mice fed the same diet. Similarly, the BA pool size for CA-fed null mice was substantially FXR/BAR-dependent manner. Thus, we hypothesized that FXR/BAR null mice would exhibit an inability to lower (2-fold) compared with wild-type mice on the same diet. Similar to the BA pool data, wild-type animals fed maintain homeostatic control over cholesterol and possibly other lipids. To test this hypothesis, wild-type and a control diet had a fecal BA excretion rate ‫-2ف‬fold greater than null mice fed the same diet ( Figure 2F ). CA FXR/BAR null mice were fed a control diet or a diet supplemented with 1% cholesterol for 28 days. Histologfeeding markedly increased (10-fold) fecal BA excretion in wild-type mice but to a lesser extent (4-fold) in null ical analysis of the livers from mice fed the control diet revealed the presence of numerous vacuoles in FXR/ mice, compared to the corresponding groups fed a control diet. Under conditions where hepatic elimination is BAR null, but not wild-type mice, that were positive for the presence of lipid as evidenced by oil red O staining impaired, BAs may undergo sulfation resulting in increased hydrophilicity and subsequent renal excretion ( Figures 3C and 3D ). After 28 days on the 1% cholesterol diet, numerous lipid-containing vacuoles were present (Bahar and Stolz, 1999). As shown in Figure 2E , wildtype and null mice exhibited similar rates of urinary BA in the livers of wild-type mice; however, these were comparatively much smaller and less numerous than excretion when fed the control diet. CA feeding increased the rate of urinary BA excretion for both genothose observed for FXR/BAR null mice fed the same diet ( Figures 3E and 3F) . Consistent with these data, types; however, null mice under these conditions had FXR/BAR null mice fed the 1% cholesterol diet had a wild-type mice. All of these parameters, with the exception of triglycerides for wild-type mice, were elevated liver/body weight ratio 1.6-fold greater than that of wildtype mice fed the same diet ( Figure 4A ). Similarly, hefor both genotypes in response to administration of the 1% cholesterol diet for 28 days. Similar to the data patic cholesterol and triglyceride contents were greater (1.4-and 2.4-fold, respectively) for FXR/BAR null versus obtained with the control diet, serum total cholesterol, phospholipid and triglyceride levels for FXR/BAR null wild-type mice fed the 1% cholesterol diet (Figures 4B  and 4C ). The hepatic triglyceride content of FXR/BAR versus wild-type mice were significantly greater when fed the 1% cholesterol diet. FPLC analysis of the serum null mice fed the control diet was also significantly greater (2.2-fold) than that for wild-type mice fed the lipoproteins ( Figure 5 ) revealed that the majority of the cholesterol eluted in the high-density lipoprotein (HDL) same diet. No differences were observed between genotypes for liver/body weight ratios or hepatic cholesterol fractions regardless of genotype or diet. However, FXR/ BAR null mice maintained on the control diet had higher content when the control diet was given, nor for hepatic phospholipid content ( Figure 4D ) regardless of diet. levels of very low-density and low-density lipoproteins (VLDL and LDL, respectively) compared with wild-type The serum lipid profiles of wild-type and FXR/BAR null mice are summarized in Table 1 . When maintained mice fed the same diet. Administration of the 1% cholesterol diet caused similar increases of HDL for both genoon the control diet, serum total cholesterol, phospholipid, triglyceride, and cholesterol ester levels for FXR/ types but increased LDL only in the FXR/BAR null mice. Consistent with these data, Western blot analysis of the BAR null mice were significantly greater than those for , 1996) , had similar mRNA levels in the livers in BA transport was examined. As shown in Figure 6A , of wild-type and null mice fed a control diet ( Figure 6A ). mRNA levels for the hepatic basolateral transporter Ntcp Because both wild-type and null mice had increased were similar for wild-type and null mice fed a control diet. However, upon feeding the 1% CA diet, Ntcp mRNA levels of hepatic mEH mRNA in response to CA feeding, Wild-type (ϩ/ϩ) and FXR/BAR null mice (Ϫ/Ϫ) mice were fed a control diet or a diet supplemented with 1% CA for 5 days. Total RNA was isolated, and 10 g were separated on a 1.1% agarose gel, transferred to a nylon membrane, and hybridized with the indicated 32 P-labeled cDNA probes. Quantitation of the bands was performed using a phosphorimager and are expressed as the fold change, after correction for ␤-actin levels, relative to wild-type mice fed a control diet. ., 1996) . This cross 1990) were prepared by RT-PCR of liver or, where appropriate, ileum total RNA. RT-PCR cloning of the FXR/BAR null mouse mRNA was produced chimeric heterozygous mice possessing both the wildtype FXR/BAR allele and a continuum of potential deletions of the achieved using oligo(dT) 30 for both cDNA synthesis and PCR amplification and FXR11 (5Ј-tcatattaacagaaatggcaaccagtcatg-3Ј) as the targeted allele. Male mice highly chimeric for the null allele were crossed with wild-type female C57BL/6N mice. Black-coated offupstream PCR primer. Probes were 32 P-labeled by the random primer method using Ready-to-Go DNA labeling beads (Amershamspring heterozygous for the null allele and not possessing the Cre transgene were crossed and used to establish the lines used in Pharmacia Biotech, Piscataway, NJ). Hepatic nuclei were prepared by crushing 0.5 g of frozen tissue these studies. Routine genotyping of FXR/BAR mice was performed using the primers F1: 5Ј-tctctttaagtgatgacgggaatct-3Ј; F2: 5Ј-gct using a mortar and pestle on dry ice. The resulting powder was transferred to a chilled Dounce homogenizer and homogenized, on ctaaggagagtcacttgtgca-3Ј; and R1: 5Ј-gcatgctctgttcataaacgccat-3Ј. Primers F1/R1 predict a 249 bp product, which is preferentially ice, in 10 ml of nuclei buffer (15 mM Tris-HCl, pH 7.4, containing 60 mM KCl, 15 mM NaCl, 5 mM MgCl 2 , 0.1 mM EGTA, 0.5 mM amplified over the 1989 bp F2/R1 product, for the wild-type allele. Primers F2/R1 predict a 291 bp product for the null allele. All amplifidithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride, and 300 mM sucrose). The homogenate was filtered through gauze and centrications were performed with 250 ng of genomic DNA using 1.25 U AmpliTaq DNA polymerase (Perkin-Elmer, Norwalk, CT) in the fuged at 4,500 ϫ g for 4 min at 4ЊC. The resulting pellet was resuspended in 5 ml of nuclei buffer, layered over 2.5 ml of nuclei buffer presence of 2.5 mM MgCl 2 , 200 M of each dNTP, and 1 M of each primer in a final volume of 25 l. The following thermal-cycling containing 1.7 M sucrose, and centrifuged at 23,000 ϫ g for 1 hr at 4ЊC. After aspirating the supernatant, the pellet was resuspended profile was used for all PCR reactions: 1 cycle of 5 min at 95ЊC; 30 cycles of 45 s at 95ЊC, 45 s at 60ЊC, and 45 s at 72ЊC; and 1 cycle in 500 l of nuclei buffer, snap frozen in liquid N 2 , and stored at Ϫ80ЊC
